PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis
Marie-Claude Durpès(Université de Sherbrooke), Pedro Geraldes(Université de Sherbrooke), George L. King(Joslin Diabetes Center), Marie‐Odile Guimond(Université de Sherbrooke), Judith Paquin-Veillet(Université de Sherbrooke), Martin Paré(Université de Sherbrooke), Catherine Morin(Université de Sherbrooke), Mark D. Rekhter(Memorial Hermann), R. Béland(Université de Sherbrooke)
Cited by 72
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k